{"id":"W4405364984","doi":"10.1016/j.msard.2024.106120","title":"159. Cladribine Tablets Use in People with Multiple Sclerosis Up to 4 Years and Beyond Following Treatment Initiation: Results from Multi-country Patient Support Programmes","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Medicine; Multiple sclerosis; Relapsing remitting; Pediatrics; Physical therapy; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002214884,0.0004391528,0.000587722,0.0004163354,0.0001816742,0.0002761973,0.00008656967,0.0003095397,0.00003465839],"category_scores_gemma":[0.000409442,0.0003395926,0.0001192106,0.00099292,0.0001421363,0.0003954261,0.0001361732,0.000355528,0.00002517298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005670259,"about_ca_system_score_gemma":0.0003093753,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009766504,"about_ca_topic_score_gemma":0.01069107,"domain_scores_codex":[0.9969478,0.00008739091,0.000668974,0.001057815,0.0005463962,0.0006915865],"domain_scores_gemma":[0.9983094,0.0006954246,0.00008713095,0.0003977077,0.00006869726,0.0004415989],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005421932,0.001772555,0.768049,0.0001914309,0.001617757,0.0004711186,0.04641741,0.0009436627,0.008749466,0.00001213597,0.001997253,0.1643563],"study_design_scores_gemma":[0.05212638,0.002678653,0.8665065,0.002067295,0.0005019677,0.00003032784,0.00596913,0.06392753,0.0007163759,0.00001153512,0.004636645,0.0008277016],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945893,0.001320405,0.00009070999,0.0009784342,0.0003110972,0.001951963,0.000489798,0.0001832408,0.0000850272],"genre_scores_gemma":[0.9937754,0.00193068,0.002449928,0.0002055318,0.0000303843,0.000282025,0.0009173745,0.0001008067,0.0003078949],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1635286,"threshold_uncertainty_score":0.9999056,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02897219515397852,"score_gpt":0.2474376461445344,"score_spread":0.2184654509905558,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}